The Protective Effect of Losartan on Diabetic Neuropathy in a Diabetic Rat Model

被引:17
作者
Cavusoglu, T. [1 ,2 ]
Karadeniz, T. [3 ]
Cagiltay, E. [4 ]
Karadeniz, M. [5 ]
Yigitturk, G. [1 ]
Acikgoz, E. [1 ]
Uyanikgil, Y. [1 ,2 ]
Ates, U. [6 ]
Tuglu, M. I. [7 ]
Erbas, O. [8 ]
机构
[1] Ege Univ, Dept Histol & Embryol, Fac Med, Izmir, Turkey
[2] Ege Univ, Cord Blood Cell & Tissue Res & Applicat Ctr, Izmir, Turkey
[3] Izmir Tepecik Training & Res Hosp, Dept Pathol, Izmir, Turkey
[4] GATA Haydarpasa Teaching Hosp, Dept Endocrinol & Metab, Istanbul, Turkey
[5] Sifa Univ, Fac Med, Dept Endocrinol, Izmir, Turkey
[6] Bilim Univ, Dept Histol & Embryol, Fac Med, Istanbul, Turkey
[7] Celal Bayar Univ, Fac Med, Dept Histol & Embryol, Manisa, Turkey
[8] Bilim Univ, Dept Physiol, Fac Med, Istanbul, Turkey
关键词
medicine; losartan; diabetes; electromyography; histopathological; NERVE GROWTH-FACTOR; ANGIOTENSIN-II; ACE-INHIBITOR; RISK-FACTORS; BLOOD-FLOW; LISINOPRIL; BLOCKADE; MECHANISMS; NEURONS; BDNF;
D O I
10.1055/s-0035-1550019
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aim: Involvement of the peripheral and autonomic nervous systems is possibly the most frequent complication of diabetes. Important risk factors included hyperglycemia, dyslipidemia, hypertension, and smoking. Angiotensin-converting-enzyme inhibitor (ACE) inhibitors should be beneficial in all vascular beds, including neuropathy and retinopathy. In this study we aimed to evaluate the effect of the angiotensin receptor blocker losartan on diabetic neuropathy in a diabetic rat model. Material and Methods: 24 male, Sprague Dawley albino mature rats were divided into 3 groups; (1) control group: No drug was administered to the remainder of rats which blood glucose levels were under 120mg/dl, (2) diabetic control: rats were given no medication, but 4ml per day of tap water was given by oral gavage, (3) losartan groups: rats were given 10mg/kg/day oral of losartan for 4 weeks. Electromyography (EMG) was applied to anesthetized rats at the end of 4(th) weekend. Then, the animals were euthanized and sciatic nerve was performed for histopathological examination. Results: Compound Muscle Action Potential (CMAP) amplitude of diabetic rats receiving the Saline in the EMG was significantly reduced when compared to the control group. Distal latency value and CMAP duration of diabetic rats receiving the saline were meaningfully increased when compared to the control group. CMAP amplitude and CMAP duration of diabetic rats receiving the Losartan treatment in the EMG were meaningfully reduced when compared to diabetic rats receiving the Saline. Perineural thickness in the rats receiving the Losartan treatment was found to be significantly reduced when compared to the group receiving the Saline. Conclusions: As a result, it has been shown in this study that perineural thickness of the Losartan treatment was significantly reduced when compared to saline receiving group, significantly increased the immunoexpression of NGF, and also provided a significantly recovery in EMG when compared to Saline receiving group.
引用
收藏
页码:479 / 484
页数:6
相关论文
共 40 条
[1]
Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats [J].
Aggarwal, M ;
Singh, J ;
Sood, S ;
Arora, B .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (03) :131-134
[2]
Althaus HH, 2004, PROG BRAIN RES, V146, P415
[3]
[Anonymous], AM J CLIN P
[4]
[Anonymous], AM J CLIN P
[5]
[Anonymous], IRANAN J DIABETES OB
[6]
ANGIOTENSIN CONVERTING ENZYME-INHIBITION PREVENTS DEVELOPMENT OF MUSCLE AND NERVE DYSFUNCTION AND STIMULATES ANGIOGENESIS IN STREPTOZOTOCIN-DIABETIC RATS [J].
CAMERON, NE ;
COTTER, MA ;
ROBERTSON, S .
DIABETOLOGIA, 1992, 35 (01) :12-18
[7]
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy [J].
Cameron, NE ;
Eaton, SEM ;
Cotter, MA ;
Tesfaye, S .
DIABETOLOGIA, 2001, 44 (11) :1973-1988
[8]
Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? [J].
Chaldakov, GN ;
Fiore, M ;
Stankulov, IS ;
Manni, L ;
Hristova, MG ;
Antonelli, A ;
Ghenev, PI ;
Aloe, L .
NGF AND RELATED MOLECULES IN HEALTH AND DISEASE, 2004, 146 :279-289
[9]
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J].
Chaturvedi, N ;
Sjolie, AK ;
Stephenson, JM ;
Abrahamian, H ;
Keipes, M ;
Castellarin, A ;
Rogulja-Pepeonik, Z ;
Fuller, JH .
LANCET, 1998, 351 (9095) :28-31
[10]
ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats [J].
Coppey, LJ ;
Davidson, EP ;
Rinehart, TW ;
Gellett, JS ;
Oltman, CL ;
Lund, DD ;
Yorek, MA .
DIABETES, 2006, 55 (02) :341-348